CASI Pharmaceuticals Inc (NASDAQ:CASI)

3.85
Delayed Data
As of Feb 23
 +0.10 / +2.67%
Today’s Change
0.91
Today|||52-Week Range
4.84
+18.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash15.1M10.7M5.1M27.1M
 
 
 
 
 
Short Term Investment Cash7.1M-4.5M-5.5M22.0M
 
 
 
 
 
Cash & Short Term Investments15.1M10.7M5.1M27.1M
 
 
 
 
 
 
ReceivablesReceivables0.0023.7K0.000.00
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets279.8K328.2K438.2K355.9K
 
 
 
 
 
Current Assets15.4M11.0M5.6M27.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross255.1K486.9K512.3K491.6K
 
 
 
 
 
Depreciation-177.0K-225.2K-293.5K-262.0K
 
 
 
 
 
Other Assets18.0K26.0K38.2K34.5K
 
 
 
 
 
Total Assets15.5M11.3M5.8M27.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable0.00491.6K884.1K1.1M
 
 
 
 
Accrued Expenses400.0K417.8K165.4K251.0K
 
 
 
 
 
Other Current Liabilities565.2K427.4K169.5K251.0K
 
 
 
 
 
Other Liabilities565.2K919.0K1.1M1.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.001.4M1.5M1.5M
 
 
 
 
Other Liabilities0.009.4M9.4M4.1M
 
 
 
 
Total Liabilities565.2K11.7M11.9M6.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity14.9M-422.2K-6.1M20.8M
 
 
 
 
 
Total Shareholder Equity14.9M-422.2K-6.1M20.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding27.0M32.4M32.4M60.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.